Intravenous single dose of tranexamic acid safely reduces blood loss and the need for transfusion in elderly patients with hip fracture. A randomized double-blinded controlled trial at 1-year follow-up

• Hlavní autoři: Francisco A Miralles-Muñoz (Autor), Rosario Martin-Grandes (Autor), Daniel Martinez-Mendez (Autor), Gerard Mahiques-Segura (Autor), Alejandro Lizaur-Utrilla (Autor), María Flores Vizcaya-Moreno (Autor)
• Médium: Kniha
• Vydáno: Annals of Musculoskeletal Medicine - Peertechz Publications, 2023-11-21.
• Témata: Research Article
• On-line přístup: Connect to this object online.

<p>Background: A hip fracture usually presents significant blood loss in the perioperative period, with a transfusion rate of 20-60%. In order to reduce the complications associated with this procedure, the administration of Tranexamic Acid (TXA) has been implemented in the treatment of periop...